Saturday, January 09, 2021 8:25:36 AM
No way CD12 reaches stat significance - we are talking about Leronlimab not Remdeathisnear which by the way my friend was given 3 times as his status got worse and worse 2 days after Leronlimab he is using 60% less ventilator and this is someone 6 weeks removed from a lung transplant with covid 19 that’s over 65 . I’m not sure where your getting information that would suggest Leronlimab will not show stat significance unless you are privy to information the rest of us don’t have. Our management is not perfect by a long shot but I will say this Dr. Scott Kelly was instrumental in my friend receiving Leronlimab as quickly as he did once the doctors finally got on board. We still have a long way to go as far as him recovering and it’s still a long shot but the drug works. I can’t speak for everyone but in my personal experience with CyDy management especially Dr.Kelly and Leronlimab I’m very impressed. Is there frustration on my part with the HIV BLA you damn right there is I’m not at all happy with how slow and mistake riddled this process has been. We are a small biotech company pre-revenue trying to get a landmark drug approved with a crooked FDA controlled by big pharma that does not want us approved. It’s frustrating for everyone who is heavily invested in this company as I’m sure many of us are. In less than two weeks we will all be very happy or it is going to be over but if I had it to do over I would invest just like I have done the first time anyone who can’t handle the pressure get out and invest in coca-cola or Walmart something not so stressful but I like a good fight . Ladies and gentlemen we are in one so take it all in breathe the air around you and enjoy the fact that you are alive and have this opportunity to endorse a drug and cause worth fighting for no one said it was going to be easy but it will be life changing my friend who is fighting for his believed in this cause and in this drug as he is fighting for his life the last thing he told me was give it your best shot at getting me Leronlimab and that’s all we can do is give our best .GLTA
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/21/2026 04:15:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2026 09:08:39 PM
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
